Internal medicine

Hazard ratio

FOLFIRI

FOLFOX

Oxaliplatin

Colorectal cancer

Meta-analysis

Cancer

Oncology

Neutropenia

Anemia

Chemotherapy

Cisplatin

Carboplatin

Irinotecan

Confidence interval

Medicine

The Oncologist

Chemotherapy-induced toxicities lead to therapy dose reduction or delay, affecting patient outcomes. This systematic review and meta-analysis evaluated the impact of relative dose intensity (RDI) on survival in adult patients with solid tumor cancer on nonadjuvant-based chemotherapy regimens.

Relative Dose Intensity of Chemotherapy and Survival in Patients with Advanced Stage Solid Tumor Cancer: A Systematic Review and <scp>Meta-Analysis</scp>

Relative Dose Intensity of Chemotherapy and Survival in Patients with Advanced Stage Solid Tumor Cancer: A Systematic Review and Meta-Analysis